
About Abreos Biosciences
Abreos Biosciences is a Healthcare company based in San Diego (United States) founded in 2013. Developing point-of-care tests for personalized dosing and counterfeit detection of biologic drugs. Abreos Biosciences has raised $725 thousand across 12 funding rounds from investors including HHS, SBIR and tritontechnologyfund.com. Its focus areas include Life Sciences, Toxicology and In Vitro Diagnotic Tests. Its legal entity is Abreos Biosciences, Inc. Its competitors include IntegenX, Precision Diagnostics and Ameritox; 1 of its 3 listed competitors has raised funding.
Company details
Founded in 2013 in San Diego, United States, Abreos Biosciences operates in the biotechnology sector, focusing on diagnostic assays for biologic drugs. The Veritope platform is utilized to create mimetope peptides that replicate ligands targeted by monoclonal antibodies. These peptides enable quantitative detection in serum, blood, or compounding solutions via ELISA or lateral flow methods. Applications include pharmacokinetics monitoring and counterfeit identification for antibody therapies.
- Headquarters San Diego, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website abreos.com
- Social LinkedIn X
- Legal Name Abreos Biosciences, Inc.
- Total Equity Funding$725K (USD)
in 12 rounds
- Latest Funding Round$1.88M (USD), Grant
Feb 2018
- InvestorsHHS
& 2 more
Funding Insights of Abreos Biosciences
Abreos Biosciences has successfully raised a total of $725K across 12 strategic funding rounds. The most recent funding activity was a Grant round of $1.88 million completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $725,000
- Total Rounds 12
- Last Round Grant β $1.88M
- First Round $172,406
(Apr 2014)
- Investors Count 3
Latest 10 of 12 funding rounds of Abreos Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2018 | $1.88M | Grant | β | β | |
| Sep 2017 | $1.48M | Grant | β | β | |
| Sep 2017 | $224,165 | Grant | β | β | |
| Jun 2017 | $1.2M | Debt – Conventional | β | β | β |
| Jun 2016 | $725,000 | Seed | β | tritontechnologyfund.com | β |
| Apr 2016 | $475,000 | Debt – Conventional | β | β | β |
| Mar 2016 | $240,000 | Debt – Conventional | β | β | β |
| Sep 2015 | $224,811 | Grant | β | β | |
| Mar 2015 | $214,428 | Grant | β | β | |
| Jan 2015 | Grant | β | β |
3 investors in total: 3 institutional.
Investors in Abreos Biosciences
Abreos Biosciences has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, SBIR and tritontechnologyfund.com.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Federal innovation and scientific achievement services are provided. | 1982 | sbir.gov | Lithia Springs, United States | |
| tritontechnologyfund.com |
Investor details for Abreos Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Abreos Biosciences
1 people are tracked at Abreos Biosciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
Bradley Messmer | Chief Executive Officer | Leadership |
Complete people profiles for Abreos Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Abreos Biosciences
3 dated milestones of Abreos Biosciences across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Abreos Biosciences is founded.
- Funding First funding round of $172K.
- Funding Latest funding round, Grant, of $1.9M.
Competitors of Abreos Biosciences
Abreos Biosciences has 3 listed competitors in our database, 1 of them funded. They include IntegenX, Precision Diagnostics and Ameritox.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| integenx.com | 2006 | Pleasanton, United States | $92.06M | 78 | Instruments for rapid human DNA identification are developed. | |
| precisiondxlab.com | 2011 | San Diego, United States | 358 | Quantitative urine drug testing is provided for patient monitoring. | ||
| ameritox.com | 1996 | Baltimore, United States | Pain medication monitoring solutions are provided for US clinicians. |
Detailed competitors of Abreos Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Toxicology
3 companies that operate in the same segment as Abreos Biosciences (Toxicology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutic solutions for food allergies are developed via antibody platforms. | 2019 | San Francisco, California, United States | USD 75 M | |||
Therapeutics for substance use disorders, including opioid-related conditions, are developed. | 2020 | Oakland, California, United States | USD 70 M | |||
Drug delivery solutions via single-walled carbon nanotubes are offered. | 2008 | Houston, Texas, United States | USD 2.5 M | USD 5.07 M | 9 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Abreos Biosciences
Complete news archive for Abreos Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abreos Biosciences
Abreos Biosciences was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Abreos Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Abreos Biosciences is a funded company, having raised a total of $725K across 12 funding rounds to date.
Founded in 2013 in San Diego, United States, Abreos Biosciences operates in the biotechnology sector, focusing on diagnostic assays for biologic drugs. The Veritope platform is utilized to create mimetope peptides that replicate ligands targeted by monoclonal antibodies. These peptides enable quantitative detection in serum, blood, or compounding solutions via ELISA or lateral flow methods. Applications include pharmacokinetics monitoring and counterfeit identification for antibody therapies.
Abreos Biosciences's top competitors include IntegenX, Precision Diagnostics and Ameritox.
Abreos Biosciences operates through Abreos Biosciences, Inc..
